本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Aligos Therapeutics, Inc.

7.47
+0.54007.79%
盤後7.37-0.1000-1.34%19:33 EDT
成交量:9.36萬
成交額:68.43萬
市值:4,664.72萬
市盈率:-1.02
高:7.54
開:6.93
低:6.71
收:6.93
52周最高:13.69
52周最低:3.98
股本:624.46萬
流通股本:370.27萬
量比:1.40
換手率:2.53%
股息:- -
股息率:- -
每股收益(TTM):-7.3016
每股收益(LYR):-2.4500
淨資產收益率:-113.59%
總資產收益率:-49.12%
市淨率:1.46
市盈率(LYR):-3.05

資料載入中...

2024/08/20

重要事件披露

Form 8-K - Current report
2024/08/09

重要事件披露

Form 8-K - Current report
2024/08/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/06

重要事件披露

Form 8-K - Current report
2024/06/28

重要事件披露

Form 8-K - Current report
2024/05/31

重要事件披露

Form 8-K - Current report
2024/05/22

重要事件披露

Form 8-K - Current report
2024/05/15

重要事件披露

Form 8-K - Current report
2024/05/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/07

重要事件披露

Form 8-K - Current report
2024/03/12

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/12

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/12

重要事件披露

Form 8-K - Current report
2024/02/28

重要事件披露

Form 8-K - Current report
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/14

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals